Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

Share Price is delayed by 15 minutes
Get Live Data
2,178.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 28.00 (1.277%)
Market Cap: £1.45b
GNS Live PriceLast checked at - London Stock Exchange

Intraday Genus Share Chart

Director/PDMR Shareholding

15 Sep 2009 14:32

RNS Number : 0931Z
Genus PLC
15 September 2009
 

15 September 2009

FOR IMMEDIATE RELEASE 

GENUS plc

('Genus' or 'the Company')

Directors' and PDMRs' Share Options

Genus announces that conditional nil-cost share options were granted under the Genus 2004 Performance Share Pla("the Plan") today to Richard Wood, Chief Executive, as to 68,755 ordinary shares of 10 pence each in the Company ("Shares")to John Worby, Group Finance Director, as to 42,017 Shares, to Ian Biggs, Chief Operating Officer, The Americas as to 30,558 Shares, to Thomas Philip Acton, Chief Operating Officer, Europe & Asia as to 30,558 shares, to Ian Farrelly, Group Company Secretary & General Counsel as to 22,154 shares and to David Crosby, Group Financial Controller as to 19,404 shares.

These options are subject to performance conditions which relate to growth in the Company's earnings per share over a three year period and which trigger vesting on an incremental basis.

Richard Wood's direct shareholding in the Company stands at 120,856 Shares representing 0.203% of the issued share capital of the Company that is currently 59,563,973 Shares. In addition, he is the beneficial owner of 292,465 conditional shares and nil-cost options.

John Worby's direct shareholding stands at 10,000 Shares representing 0.016% of the issued share capital of the Company. In addition, he is the beneficial owner of 128,540 nil-cost options

Ian Biggs' direct shareholding stands at 30,152 Shares representing 0.051% of the issued share capital of the Company. In addition, he is the beneficial owner of 116,490 conditional shares and nil-cost options

Thomas Philip Acton's direct shareholding stands at 37,864 Shares representing 0.064% of the issued share capital of the Company. In addition, he is the beneficial owner of 109,185 conditional shares and nil-cost options.

Ian Farrelly has no direct shareholding in the Company and is the beneficial owner of 70,277 nil-cost share options and 9,534 market value share options. 

David Crosby has no direct shareholding in the Company and is the beneficial owner of 19,404 nil-cost share options and 16,373 market value share options. 

 

For further information please contact:

 

Ian Farrelly

Group Company Secretary & General Counsel 

Genus plc  Tel: 01256 345996

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSUVOORKARKAAR
Date   Source Headline
13th May 202612:32 pmRNSDirector/PDMR Shareholding
1st May 20269:20 amRNSTotal Voting Rights
13th Apr 20265:59 pmRNSDirector/PDMR Shareholding
1st Apr 20269:40 amRNSDirector/PDMR Shareholding
10th Mar 20263:56 pmRNSNotification of Major Holdings
10th Mar 20263:56 pmRNSNotification of Major Holdings
4th Mar 202610:33 amRNSDirector/PDMR Shareholding
4th Mar 202610:08 amRNSDirector Declaration
27th Feb 202612:48 pmRNSDirector/PDMR Shareholding
26th Feb 20267:00 amRNSInterim Results
2nd Feb 202612:39 pmRNSBlock Listing Return
2nd Feb 202611:21 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSSuccessful formation of Chinese porcine JV
23rd Jan 20265:23 pmRNSPRP Regulatory Progress – Canada
16th Jan 20267:00 amRNSHalf Year Trading Update – Ahead of expectations
27th Nov 20257:00 amRNSDirector/PDMR Shareholding
19th Nov 202512:12 pmRNSResults of AGM
19th Nov 20257:00 amRNSNon-Executive Director Appointments
19th Nov 20257:00 amRNSAGM Trading Update
3rd Nov 202510:56 amRNSTotal Voting Rights
14th Oct 20254:02 pmRNSNotification of Major Holdings
10th Oct 20257:00 amRNSNotice of AGM
1st Oct 20259:47 amRNSTotal Voting Rights
25th Sep 20254:49 pmRNSDirector/PDMR Shareholding
24th Sep 202511:35 amRNSDirector/PDMR Shareholding
19th Sep 20252:39 pmRNSDirector/PDMR Shareholding
17th Sep 202512:14 pmRNSDirector/PDMR Shareholding
11th Sep 202512:20 pmRNSDirector/PDMR Shareholding
8th Sep 20254:05 pmRNSAdditional Listing
4th Sep 20257:00 amRNSPreliminary results
4th Sep 20257:00 amRNSAccelerated Chinese porcine JV formation
28th Aug 20254:57 pmRNSNotification of Major Holdings
19th Aug 20253:03 pmRNSNotification of Major Holdings
19th Aug 20257:00 amRNSNotification of Major Holdings
6th Aug 202510:51 amBUSHolding(s) in Company
4th Aug 202511:14 amRNSNotification of Major Holdings
1st Aug 202510:10 amRNSBlock Listing Six Monthly Return
1st Aug 202510:05 amRNSTotal Voting Rights
15th Jul 20257:00 amRNSFY25 Trading Update
9th May 20259:25 amRNSAppointment of Financial Adviser & joint Broker
1st May 20252:28 pmRNSTotal Voting Rights
30th Apr 20257:00 amRNSPRRS Resistant Pig – FDA Approval
25th Apr 20254:30 pmRNSNotification of Major Holdings
25th Apr 20254:28 pmRNSNotification of Major Holdings
2nd Apr 20255:08 pmRNSDirector/PDMR Shareholding
2nd Apr 20253:43 pmRNSNotification of Major Holdings
13th Mar 20257:00 amRNSAppointment of Chief Financial Officer Designate
3rd Mar 202511:32 amRNSTotal Voting Rights
28th Feb 20251:30 pmRNSDirector/PDMR Shareholding
27th Feb 20257:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.